Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of British Columbia

$21,000.00

""Multimodal Optical Imaging Endoscopy for Noninvasive """"Optical Biopsy"""" in Tissues""

FY 2012-13

Summary
Lung cancer is the foremost cause of cancer death in Canada. In 2011, lung cancer is estimated to account for 11,300 of cancer deaths in men and 9,300 in women. Early detection and treatment has the potential to greatly improve these statistics. The current gold standard of cancer diagnosis is tissue biopsy followed by histopathology. In this procedure, clinicians take multiple tissue biopsies from suspicious areas and perform histopathology examination. This procedure is invasive and time consuming. ""Optical biopsy"" is a new type of tool which uses optical imaging to examine subcellular tissue morphology in vivo. It can provide the same imaging resolution as histopathology but the procedure is noninvasive and in real-time. Therefore, ""optical biopsy"" can potentially have a huge impact on the diagnosis and treatment of cancer and other diseases. We propose to develop a multimodal optical imaging endoscopy for noninvasive ""optical biopsy"" of the lung. The endoscope will combined optical coherence tomography (OCT) and multiphoton microscopy (MPM). OCT provides cross-sectional anatomical imaging of layered tissue structures over a few millimeters deep and wide. It detects backscattered light from refractive index discontinuities. MPM images cells and extracellular matrix in turbid tissues with subcellular resolution. MPM provides functional information about biochemical specificity of collagen, elastin, NADH, and flavins. When developed into a single endoscope, MPM/OCT can provide multiple contrasts and multiscale field-of-views. The proposal will develop endoscopic MPM/OCT using optical fibers, miniature scanners, and micro-optics. The design will be optimized for simultaneous large field-of-view OCT and high resolution MPM imaging. The endoscope will be capable to quickly scan over a large tissue area to find abnormal regions with OCT, and perform a high-resolution zoom-in imaging on the regions of interest to identify the abnormalities with MPM. The development from this project will serve as an important tool for diagnosing and evaluating the effect of treatment of major respiratory diseases.
Program
Discovery Grants Program - Individual
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
341640-2012
Name nom
Tang, Shuo
Department département
Electrical and Computer Engineering
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
21000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1510
Committee name en
Electrical and Computer Engineering
Committee name fr
Génie électrique et informatique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
5
Application title
""Multimodal Optical Imaging Endoscopy for Noninvasive """"Optical Biopsy"""" in Tissues""
Keyword
NSERC
Application summary
Lung cancer is the foremost cause of cancer death in Canada. In 2011, lung cancer is estimated to account for 11,300 of cancer deaths in men and 9,300 in women. Early detection and treatment has the potential to greatly improve these statistics. The current gold standard of cancer diagnosis is tissue biopsy followed by histopathology. In this procedure, clinicians take multiple tissue biopsies from suspicious areas and perform histopathology examination. This procedure is invasive and time consuming. ""Optical biopsy"" is a new type of tool which uses optical imaging to examine subcellular tissue morphology in vivo. It can provide the same imaging resolution as histopathology but the procedure is noninvasive and in real-time. Therefore, ""optical biopsy"" can potentially have a huge impact on the diagnosis and treatment of cancer and other diseases. We propose to develop a multimodal optical imaging endoscopy for noninvasive ""optical biopsy"" of the lung. The endoscope will combined optical coherence tomography (OCT) and multiphoton microscopy (MPM). OCT provides cross-sectional anatomical imaging of layered tissue structures over a few millimeters deep and wide. It detects backscattered light from refractive index discontinuities. MPM images cells and extracellular matrix in turbid tissues with subcellular resolution. MPM provides functional information about biochemical specificity of collagen, elastin, NADH, and flavins. When developed into a single endoscope, MPM/OCT can provide multiple contrasts and multiscale field-of-views. The proposal will develop endoscopic MPM/OCT using optical fibers, miniature scanners, and micro-optics. The design will be optimized for simultaneous large field-of-view OCT and high resolution MPM imaging. The endoscope will be capable to quickly scan over a large tissue area to find abnormal regions with OCT, and perform a high-resolution zoom-in imaging on the regions of interest to identify the abnormalities with MPM. The development from this project will serve as an important tool for diagnosing and evaluating the effect of treatment of major respiratory diseases.